gdc
LeukemiaLymphomaNewsworthy

Celebrating Progress and Sharing Hope: The Leukemia & Lymphoma Society to Host Free Rocky Mountain Blood Cancer Conference for Blood Cancer Patients, Survivors and Caregivers

The Leukemia & Lymphoma Society (LLS) will be hosting its 8th Annual Rocky Mountain Blood Cancer Conference on Saturday, April 7, 2018, at the Hyatt Regency Aurora-Denver Conference Center. LLS Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals.
Press Releases

DENVER, CO, TUESDAY, MARCH 20, 2018 – The Leukemia & Lymphoma Society® (LLS) will be hosting its 8th Annual Rocky Mountain Blood Cancer Conference on Saturday, April 7, 2018, at the Hyatt Regency Aurora-Denver Conference Center. LLS Blood Cancer Conferences are free education events for blood cancer patients, survivors, caregivers, family members and healthcare professionals.

Local experts from the Colorado Blood Cancer Institute, Kaiser Permanente, Rocky Mountain Cancer Centers and University of Colorado will be updating attendees on the latest in blood cancer research and treatments. Additionally, Caregiver Support will be addressed in the keynote speech by Kimberly Alexander, Principal Consultant at KimCONNECTS.

Conference attendees can look forward to topics like:

  • Car-T Cell Therapies
  • Diagnosis Specific Information
  • Health and Wellness
  • Survivorship and Life After Cancer

“Every year hundreds of patients, caregivers and healthcare providers come together to educate themselves on blood cancer. We are pleased to offer this conference to our community and to see first-hand the impact it has on our residents.” –Rebecca Russell, Executive Director, Rocky Mountain Chapter of The Leukemia & Lymphoma Society

LLS is a catalyst for collaboration within the cancer ecosystem, bringing together industry, government, healthcare providers and academia to develop new and better therapies and accelerate cures. Blood cancer research is the gateway to treatments for many cancers and other serious diseases. LLS is doing more than any health non-profit organization to advance cures and access for blood cancer patients and is having an impact beyond the blood cancers.

The conference enables blood cancer patients and caregivers to network, share, and feel empowered.

For additional information or to register, please visit https://www.eiseverywhere.com/ehome/rmbcc18/641031/ or call (720) 440-8627.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.

Founded in 1949 and headquartered in Rye Brook, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.

THE ROCKY MOUNTAIN CHAPTER OF THE LEUKEMIA & LYMPHOMA SOCIETY
720 S. COLORADO BLVD., STE 500-S, DENVER, CO 80246
720-440-8620

Recommended For You
Mantle-Cell LymphomaLymphoma
What Is Mantle-Cell Lymphoma?
Mantle-cell lymphoma is one of 70 subtypes of non-Hodgkin lymphoma. Although the precise cause is not known, the same genetic abnormality has been identified in a high percentage of patients.
Mantle-Cell LymphomaLymphoma
Diagnosing Mantle-Cell Lymphoma
Common signs and symptoms of mantle-cell lymphoma may be similar to other conditions. A comprehensive workup including a physical examination, lab tests, and imaging may be required to establish a definitive diagnosis and identify the disease stage.
Mantle-Cell LymphomaLymphoma
Initial Treatment of Mantle-Cell Lymphoma
A number of treatment options are available for patients with mantle-cell lymphoma. The specific choice of treatment may depend on the stage of the disease, symptoms, and the patient’s age and health status.
Mantle-Cell LymphomaLymphoma
Working with the Treatment Team
Patients and their loves ones should take part in key decisions regarding their care, and it is therefore important for patients to communicate their perspective during the shared treatment decision-making process.
Last modified: March 27, 2018

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country